HYTN Awarded Drug Establishment License from Health Canada, Able to Export Cannabis Pharmaceutical Products Globally

HYTN Innovations Inc., a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, announces that it has been granted a Drug Establishment License (DEL) by Health Canada.